Point-of-care HbA1c Testing Benefits

Diabetes care is placing ever-growing demands on health systems around the world. It’s time for POC diabetes testing to evolve with a solution that is simple, adaptable, and scalable to meet the needs of healthcare professionals and patients in diverse clinical practice settings. 

With POC screening, on-site testing, results, medication changes, and patient education occur in one visit. Fewer visits save patients time and money and help reduce costs for the healthcare system.

This series of brief videos provides a view of chronic disease management from the perspective of a nurse, doctor, and patient. Having HbA1c testing available at the point of care can provide a better approach to disease management – for both the clinicians and their patients.

Atellica® DCA Analyzer is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.

With limited resources, clinics need to manage an increasing volume of testing while maintaining optimal workflow in their practice. A diabetes management solution needs to be simple and intuitive to use

Atellica® DCA Analyzer is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.

High patient volume and time constraints are the new normal in modern physician offices and clinics. A diabetes management solution should provide fast HbA1c results, deliver confidence, and enable immediate patient consultation.

Atellica® DCA Analyzer is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.

Testing for HbA1c should be more convenient. Point-of-care screening increases patient engagement and can help motivate patients to make healthy choices. Maintaining their blood glucose within target ranges can help patients avoid diabetes complications.


The incidence and prevalence of diabetes are increasing. According to the 2021 IDF Diabetes Atlas, 537 million adults ages 20-79 are living with diabetes (1 in 10 adults globally). Almost half of those are undiagnosed.1

1